Pressure BioSciences, Inc. to Discuss Third Quarter 2012 Financial Results and Provide Business Update
SOUTH EASTON, Mass., Nov. 14, 2012 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2012 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:
Date: Thursday, November 15, 2012
Time: 4:15 p.m. Eastern Standard Time (EST)
To attend this teleconference via web-cast, please go to the Company's website: www.pressurebiosciences.com
To attend this teleconference via telephone:
Dial-in: (800) 875-3456 (U.S.); (800) 648-0973 (Canada); (302) 607-2001 (Int'l)
For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call and will be accessible through the Company's website.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications.
For more information about PBI and this press release, please click on the following link: http://www.pressurebiosciences.com
|
Investor Contacts: |
|
|
Richard T. Schumacher, President & CEO |
Pressure BioSciences, Inc. |
|
Joseph Damasio, Jr., V.P. of Finance and Adm. |
(T) 508-230-1828 |
SOURCE Pressure BioSciences, Inc.
RELATED LINKS
http://www.pressurebiosciences.com
More by this Source
Breakthrough Method for Lipid Analysis in Fecal Material Developed; New Understanding of Diseases/Disorders Related to Gut Function Possible
May 16, 2013, 09:22 ET
Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences' Patented Pressure Cycling Technology (PCT)
Apr 04, 2013, 11:07 ET
New Applications of Pressure BioSciences' PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
Mar 19, 2013, 13:00 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.